Photo from
LUNGevity Foundation/X
Aug 22, 2024, 14:04
“What do LUNGevity’s Research Awards mean to you” with Dr. Alexandre Reuben
LUNGevity Foundation shared a post on X:
” ‘By working with the patient-led advocacy groups, it’s an opportunity for me to make sure that the work we are doing in the lab has a direct impact on patient outcomes.’
Proceed to the video attached to the post.
Source: LUNGevity Foundation/X
More posts by LUNGevity Foundation on OncoDaily.
Dr. Alexandre Reuben is an Assistant Professor at MD Anderson Cancer Center and Co-Director of the Immunology Program at UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences. He is the Founder of Tenaci-T Therapeutics. His research focuses on enhancing the immune response against lung tumors.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 13:23
Apr 23, 2025, 13:17
Apr 23, 2025, 12:57
Apr 23, 2025, 11:43
Apr 23, 2025, 10:33